Overture Life Company
Overture Health is a producer of a technology developed to improve embryology. The company's technology is aimed at the automation of in vitro fertilization(IVF), including the commercialization of devices for automated cryopreservation and offers a product that offers embryo testing and freezing services.
Headquarters:
New York, New York, United States
Last Funding Type:
Series B
Investors Number:
7
Last Funding Date:
2021-05-25
Employee Number:
11-50
Total Funding:
$45,000,000
Founded Date:
01-01-2017
Estimated Revenue:
$1M to $10M
Industry:
Reproductive Health & Contraception
Funding Status:
Early Stage Venture